The global impact of COVID-19 has been profound. At the time of writing, global deaths have reached 420,000 and over 7.5 million people have been infected. As the virus begins to be understood, some forecasts predict grim long-term societal and financial consequences across multiple countries. COVID-19 has changed the way many aspects of society operate, and clinical trials are no exception.
To learn more about the impact of the COVID-19 pandemic on clinical trials, download COVID-19 and its Ripple Effect, a market report by Cerba Research.
This article was created in collaboration with the sponsoring company and the Xtalks editorial team.
Join or login to leave a comment
JOIN LOGIN